Invasive Therapies for Acute Coronary Syndromes in the COVID-19 Era.

Purpose Of Review: To identify and address the challenges associated with the care of ACS patients during the coronavirus 2019 pandemic.

Recent Findings: The COVID-19 pandemic has had a considerable global impact with over 2.0 million deaths worldwide so far.

Platypnea-Orthodeoxia Syndrome Caused by an Intracardiac Shunt.

Platypnea-orthodeoxia syndrome, a rare condition characterized by posture-related dyspnea, is usually caused by an intracardiac shunt, hepatopulmonary syndrome, or shunting resulting from severe pulmonary disease. We report the case of a 33-year-old woman who presented with increasing dyspnea and oxygen desaturation when she sat up or arose. Our diagnosis was platypnea-orthodeoxia syndrome.

Current Perspectives on Coronavirus Disease 2019 and Cardiovascular Disease: A White Paper by the Editors.

Coronavirus Disease 2019 (COVID-19) has infected more than 3.0 million people worldwide and killed more than 200,000 as of April 27, 2020. In this White Paper, we address the cardiovascular co-morbidities of COVID-19 infection; the diagnosis and treatment of standard cardiovascular conditions during the pandemic; and the diagnosis and treatment of the cardiovascular consequences of COVID-19 infection.